These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 38141802)

  • 41. Novel Lipidized Analog of Prolactin-Releasing Peptide Improves Memory Impairment and Attenuates Hyperphosphorylation of Tau Protein in a Mouse Model of Tauopathy.
    Popelová A; Pražienková V; Neprašová B; Kasperová BJ; Hrubá L; Holubová M; Zemenová J; Blum D; Železná B; Galas MC; Kuneš J; Maletínská L
    J Alzheimers Dis; 2018; 62(4):1725-1736. PubMed ID: 29614684
    [TBL] [Abstract][Full Text] [Related]  

  • 42. AMPK is abnormally activated in tangle- and pre-tangle-bearing neurons in Alzheimer's disease and other tauopathies.
    Vingtdeux V; Davies P; Dickson DW; Marambaud P
    Acta Neuropathol; 2011 Mar; 121(3):337-49. PubMed ID: 20957377
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ginkgo biloba Extract EGb761 Attenuates Hyperhomocysteinemia-induced AD Like Tau Hyperphosphorylation and Cognitive Impairment in Rats.
    Zeng K; Li M; Hu J; Mahaman YAR; Bao J; Huang F; Xia Y; Liu X; Wang Q; Wang JZ; Yang Y; Liu R; Wang X
    Curr Alzheimer Res; 2018; 15(1):89-99. PubMed ID: 28847282
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Caspase-3-dependent cleavage of Akt modulates tau phosphorylation via GSK3β kinase: implications for Alzheimer's disease.
    Chu J; Lauretti E; Praticò D
    Mol Psychiatry; 2017 Jul; 22(7):1002-1008. PubMed ID: 28138159
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Progressive human-like tauopathy with downstream neurodegeneration and neurovascular compromise in a transgenic rat model.
    Emmerson JT; Do Carmo S; Liu Y; Shalhoub A; Liu A; Bonomo Q; Malcolm JC; Breuillaud L; Cuello AC
    Neurobiol Dis; 2023 Aug; 184():106227. PubMed ID: 37454780
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cystatin C promotes tau protein phosphorylation and causes microtubule instability by inhibiting intracellular turnover of GSK3β in neurons.
    Duan J; Marcellus KA; Qin X; Wang Y; Paudel HK
    Mol Cell Neurosci; 2018 Jun; 89():1-8. PubMed ID: 29577984
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Current understanding of metal ions in the pathogenesis of Alzheimer's disease.
    Wang L; Yin YL; Liu XZ; Shen P; Zheng YG; Lan XR; Lu CB; Wang JZ
    Transl Neurodegener; 2020; 9():10. PubMed ID: 32266063
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A novel GSK-3beta inhibitor reduces Alzheimer's pathology and rescues neuronal loss in vivo.
    Serenó L; Coma M; Rodríguez M; Sánchez-Ferrer P; Sánchez MB; Gich I; Agulló JM; Pérez M; Avila J; Guardia-Laguarta C; Clarimón J; Lleó A; Gómez-Isla T
    Neurobiol Dis; 2009 Sep; 35(3):359-67. PubMed ID: 19523516
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Distribution of tau hyperphosphorylation in canine dementia resembles early Alzheimer's disease and other tauopathies.
    Abey A; Davies D; Goldsbury C; Buckland M; Valenzuela M; Duncan T
    Brain Pathol; 2021 Jan; 31(1):144-162. PubMed ID: 32810333
    [TBL] [Abstract][Full Text] [Related]  

  • 50. SLM, a novel carbazole-based fluorophore attenuates okadaic acid-induced tau hyperphosphorylation via down-regulating GSK-3β activity in SH-SY5Y cells.
    Wu X; Kosaraju J; Tam KY
    Eur J Pharm Sci; 2017 Dec; 110():101-108. PubMed ID: 28359686
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Caspase-3-Dependent Proteolytic Cleavage of Tau Causes Neurofibrillary Tangles and Results in Cognitive Impairment During Normal Aging.
    Means JC; Gerdes BC; Kaja S; Sumien N; Payne AJ; Stark DA; Borden PK; Price JL; Koulen P
    Neurochem Res; 2016 Sep; 41(9):2278-88. PubMed ID: 27220334
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Tetrandrine ameliorates cognitive deficits and mitigates tau aggregation in cell and animal models of tauopathies.
    Tong BC; Huang AS; Wu AJ; Iyaswamy A; Ho OK; Kong AH; Sreenivasmurthy SG; Zhu Z; Su C; Liu J; Song J; Li M; Cheung KH
    J Biomed Sci; 2022 Oct; 29(1):85. PubMed ID: 36273169
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Tau associated peripheral and central neurodegeneration: Identification of an early imaging marker for tauopathy.
    Marquez A; Guernsey LS; Frizzi KE; Cundiff M; Constantino I; Muttalib N; Arenas F; Zhou X; Lim SH; Ferdousi M; Ponirakis G; Silverdale M; Kobylecki C; Jones M; Marshall A; Malik RA; Jolivalt CG
    Neurobiol Dis; 2021 Apr; 151():105273. PubMed ID: 33482356
    [TBL] [Abstract][Full Text] [Related]  

  • 54. mTOR regulates tau phosphorylation and degradation: implications for Alzheimer's disease and other tauopathies.
    Caccamo A; Magrì A; Medina DX; Wisely EV; López-Aranda MF; Silva AJ; Oddo S
    Aging Cell; 2013 Jun; 12(3):370-80. PubMed ID: 23425014
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Tauopathy contributes to synaptic and cognitive deficits in a murine model for Alzheimer's disease.
    Stancu IC; Ris L; Vasconcelos B; Marinangeli C; Goeminne L; Laporte V; Haylani LE; Couturier J; Schakman O; Gailly P; Pierrot N; Kienlen-Campard P; Octave JN; Dewachter I
    FASEB J; 2014 Jun; 28(6):2620-31. PubMed ID: 24604080
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Phosphorylation of tau antagonizes apoptosis by stabilizing beta-catenin, a mechanism involved in Alzheimer's neurodegeneration.
    Li HL; Wang HH; Liu SJ; Deng YQ; Zhang YJ; Tian Q; Wang XC; Chen XQ; Yang Y; Zhang JY; Wang Q; Xu H; Liao FF; Wang JZ
    Proc Natl Acad Sci U S A; 2007 Feb; 104(9):3591-6. PubMed ID: 17360687
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Tau accumulation in the retina promotes early neuronal dysfunction and precedes brain pathology in a mouse model of Alzheimer's disease.
    Chiasseu M; Alarcon-Martinez L; Belforte N; Quintero H; Dotigny F; Destroismaisons L; Vande Velde C; Panayi F; Louis C; Di Polo A
    Mol Neurodegener; 2017 Aug; 12(1):58. PubMed ID: 28774322
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Reduction of advanced tau-mediated memory deficits by the MAP kinase p38γ.
    Ittner A; Asih PR; Tan ARP; Prikas E; Bertz J; Stefanoska K; Lin Y; Volkerling AM; Ke YD; Delerue F; Ittner LM
    Acta Neuropathol; 2020 Sep; 140(3):279-294. PubMed ID: 32725265
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Qingxin Kaiqiao Fang decreases Tau hyperphosphorylation in Alzheimer's disease via the PI3K/Akt/GSK3β pathway in vitro and in vivo.
    Liu S; Xu L; Shen Y; Wang L; Lai X; Hu H
    J Ethnopharmacol; 2024 Jan; 318(Pt B):117031. PubMed ID: 37579924
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Tau Ser208 phosphorylation promotes aggregation and reveals neuropathologic diversity in Alzheimer's disease and other tauopathies.
    Xia Y; Prokop S; Gorion KM; Kim JD; Sorrentino ZA; Bell BM; Manaois AN; Chakrabarty P; Davies P; Giasson BI
    Acta Neuropathol Commun; 2020 Jun; 8(1):88. PubMed ID: 32571418
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.